Healthy Adults
Conditions
Keywords
enema
Brief summary
The purpose of this study is to determine the patient preference for a biocompatible thermosensitive solution-gel versus water or saline (liquid) enema. The thermosensitive solution-gel is comprised of poloxamer, an inactive compound that is designated as GRAS (generally recognized as safe) by FDA. It could subsequently be used as a medium for drug delivery. The poloxamer (gel) is administered to study participants in order to assess preference and proximal distribution.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Generally healthy * Age 18 to 70 years old * Non-pregnant
Exclusion criteria
* GI complaints * Pregnancy * Patients with previous colonic surgery or current bowel injury or obstruction * Allergies to contrast
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient preference, as assessed by questionnaire | Up to 3 hours post-administration |
Countries
United States